BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22104735)

  • 1. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
    Jackson JA; Kapur U; Erşahin Ç
    Int J Surg Pathol; 2012 Apr; 20(2):146-53. PubMed ID: 22104735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias.
    Mandal R; Ghosh I; Banerjee D; Mittal S; Muwonge R; Roy C; Panda C; Vernekar M; Frappart L; Basu P
    Int J Gynecol Pathol; 2020 Jul; 39(4):384-390. PubMed ID: 32515923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between high-risk HPV infection and p16/Ki-67 abnormalities in Pap samples in a South Eastern Europe cohort.
    Shalaby NA; Tudorescu-Morjan C; Manole CG; Iacata AA; Popovici ML; Grecu LI; Curici A
    J Med Virol; 2024 Mar; 96(3):e29524. PubMed ID: 38483062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between p16/Ki-67 dual stain cytology results prior to and 6 months after LLETZ treatment for CIN and the follow-up regimen three years after treatment: a retrospective cohort study.
    Packet B; Goyens J; Weynand B; Poppe W; Dewilde K
    Arch Gynecol Obstet; 2024 Jul; 310(1):493-499. PubMed ID: 38806944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
    Srisuttayasathien M; Kantathavorn N; Luasiripanthu T; Petchjorm S; Samrarn J; Ittiamornlert P; Krisorakun W; Vanichtantikul A; Wetcho T; Saeloo S
    Taiwan J Obstet Gynecol; 2024 Mar; 63(2):192-198. PubMed ID: 38485314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
    Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
    J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection.
    Bruno MT; Scalia G; Cassaro N; Costanzo M; Boemi S
    BMC Infect Dis; 2020 Oct; 20(1):801. PubMed ID: 33121447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of combined HPV and CINtec® PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma.
    Voidăzan TS; Budianu MA; Cotoi OS; Turdean SG
    Rom J Morphol Embryol; 2024; 65(1):99-105. PubMed ID: 38527989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.
    Koshiol J; Sklavos M; Wentzensen N; Kemp T; Schiffman M; Dunn ST; Wang SS; Walker JL; Safaeian M; Zuna RE; Hildesheim A; Pfeiffer RM; Pinto LA
    Int J Cancer; 2014 Jan; 134(2):411-25. PubMed ID: 23824624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluation of negative cervical conizations: Frequency, diagnostic errors, risk factors and management.
    Lorenset LC; Percicote AP; Munhos SHO; Zanine RM
    Pathol Res Pract; 2024 May; 257():155283. PubMed ID: 38614053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity.
    Cabibi D; Giannone AG; Quattrocchi A; Lo Coco R; Formisano E; Porcasi R; Benfante V; Comelli A; Capra G
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it practical to add the p16/Ki67 immunohistochemical dual staining into liquid-based cytology for cervical cancer screening?
    Li YT; Lee NR; Chang WH
    Taiwan J Obstet Gynecol; 2024 May; 63(3):437-438. PubMed ID: 38802218
    [No Abstract]   [Full Text] [Related]  

  • 13. Up-regulation of Foxp3 participates in progression of cervical cancer.
    Zeng C; Yao Y; Jie W; Zhang M; Hu X; Zhao Y; Wang S; Yin J; Song Y
    Cancer Immunol Immunother; 2013 Mar; 62(3):481-7. PubMed ID: 22986453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical Peeling Therapy Using Phenol for the Cervico-Vaginal Intraepithelial Neoplasia.
    Maehama T; Shimada S; Sakamoto J; Shibata T; Fujita S; Takakura M; Takagi H; Sasagawa T
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005896
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of Geminin as a Tool for Augmenting Accurate Diagnosis of Cervical Neoplasia.
    Bagde ND; Bagde MN; Agrawal S; Nayak P; Negi SS; Rajbhar S; Hussain N
    Cureus; 2024 Mar; 16(3):e56864. PubMed ID: 38659554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N; Schwartz L; Zuna RE; Smith K; Mathews C; Gold MA; Allen RA; Zhang R; Dunn ST; Walker JL; Schiffman M
    Clin Cancer Res; 2012 Aug; 18(15):4154-62. PubMed ID: 22675168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
    Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
    J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
    Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
    Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16/Ki-67 immunostaining in the triage of young women with LSIL, ASC-US, and ASC-H cytology.
    Dovnik A; Repše-Fokter A
    Diagn Cytopathol; 2020 Jan; 48(1):96-97. PubMed ID: 31714671
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of p16/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer.
    Toliman PJ; Phillips S; de Jong S; O'Neill T; Tan G; Brotherton JML; Saville M; Kaldor JM; Vallely AJ; Tabrizi SN
    Clin Microbiol Infect; 2020 Jun; 26(6):748-752. PubMed ID: 31654795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.